• 1
    Murr M, Sarr M, Oishi A, van Heerden J. Pancreatic cancer. CA Cancer J Clin 1994; 44: 30418.
  • 2
    Fernandez-del Castillo C, Warshaw A. Cancer of the pancreas—surgery. In: RustgiA, editor. Gastrointestinal cancer: biology, diagnostics, and therapy. Philadelphia: Lippincott-Raven Publishers, 1995: 34150.
  • 3
    Conlon KC, Klimstra DS, Brennan MF. Long-term survival after curative resection for pancreatic ductal adenocarcinoma. Clinicopathologic analysis of 5-year survivors. Ann Surg 1996;223: 2739.
  • 4
    Janes RH, Nioderhuber JE, Chmiel JS, Winchester DP, Ocwieja KC, Karnell JH, et al. National patterns of care for pancreatic cancer. Results of a survey by the Commission on Cancer. Ann Surg 1996;223: 26172.
  • 5
    Yeo CJ, Cameron JL, Lillemoe KD, Sitzmann JV, Hruban RH, Goodman SN, et al. Pancreaticoduodenectomy for cancer of the head of the pancreas: 201 patients. Ann Surg 1995; 221: 72133.
  • 6
    Bruckner H, Kalnicki S, Dalton J, Snady H, Schwartz G, Chesser M, et al. Survival after combined modality therapy for pancreatic cancer. J Clin Gastroenterol 1993; 16: 199203.
  • 7
    Kamthan A, Morris J, Dalton J, Mandeli J, Chesser M, Lebev D, et al. Combined modality therapy for stage II and stage III pancreatic carcinoma. J Clin Oncol 1997; 15: 29207.
  • 8
    Wright-Browne V, Abbruzzese J. Cancer of the pancreas—chemotherapy and radiation therapy. In: RustgiA, editor. Gastrointestinal cancer: biology, diagnostics, and therapy. Philadelphia: Lippincott-Raven Publishers, 1995: 32540.
  • 9
    Yeo C, Abrams R, Grochow L, Sohn T, Ord S, Hruban R, et al. Pancreaticoduodenectomy for pancreatic adenocarcinoma: postoperative adjuvant chemoradiation improves survival. Ann Surg 1997; 225: 62136.
  • 10
    Spitz F, Abbruzzese J, Lee J, Pisters P, Lowy A, Fenoglio C, et al. Preoperative and postoperative chemoradiation strategies in patients treated with pancreaticoduodenectomy for adenocarcinoma of the pancreas. J Clin Oncol 1997; 15: 92837.
  • 11
    Pisters P, Abbruzzese J, Janjan N, Cleary K, Charnsangavej C, Goswitz M, et al. Rapid-fractionation preoperative chemoradiation, pancreaticoduodenectomy, and intraoperative radiation therapy for resectable pancreatic adenocarcinoma. J Clin Oncol 1998; 16: 384350.
  • 12
    Todd K, Gloor B, Lane J, Reber H. Resection of locally advanced pancreatic cancer after downstaging with continuous-infusion 5-fluorouracil, mitomycin-C, leucovorin, and dipyridamole. J Gastrointest Surg 1998; 2: 15966.
  • 13
    Hoffmann JP, Woese JL, Solin LJ, Agarwal P, Engstrom P, Scher R, et al. A single institutional experience with preoperative chemoradiotherapy for stage I-III pancreatic adenocarcinoma. Am Surg 1993; 59: 77281.
  • 14
    Hoffman J, Lipsitz S, Pisansky T, Weese JL, Solin L, Benson AB 3rd. A phase II trial of preoperative radiation therapy and chemotherapy for patients with localized resectable adennocarcinoma of the pancreas; an Eastern Cooperative Oncology Group Study. J Clin Oncol 1998; 16: 31723.
  • 15
    Merrick W, Dobelbower R. Aggressive therapy for cancer of the pancreas. Does it help? In: Steinberg W, editor. Disorders of the pancreas. Gasroenterol Clin N Am 1990; 19: 93562.
  • 16
    Douglass H. Current approaches to multimodality management of advanced pancreatic cancer. Hepatogastroenterology 1993; 40: 43342.
  • 17
    The Gastrointestinal Tumor Study Group. A multi-institutional comparative trial of radiation therapy alone and in combination with 5-fluorouracil for locally unresectable pancreatic carcinoma. Ann Surg 1979; 189: 2058.
  • 18
    Gastrointestinal Tumor Study Group. Further evidence of effective adjuvant combined radiation and chemotherapy following curative resection of pancreatic cancer. Cancer 1987; 59: 200610.
  • 19
    Gastrointestinal Tumor Study Group, Kalser M, Ellenberg S. Pancreatic cancer: adjuvant combined radiation and chemotherapy following curative resection. Arch Surg 1985; 120: 899903.
  • 20
    Wagener DIT, van Hoesel OGCM, Yap SH, Hoogenraad WJ, Wobbes T, Strijk SP. Phase II trial of 5-fluorouracil, adriamycin and cisplatin (FAP) followed by radiation and 5-fluorouracil in locally advanced pancreatic cancer. Cancer Chemother Pharmacol 1989; 25: 1314.
  • 21
    Douglass HO Jr., Strablein D. Ten-year follow-up of first generation surgical adjuvant studies of the Gastrointestinal Tumor Study Group. In: JonesS, SalmonS, editors. Adjuvant therapy of cancer. VI. Philadelphia: WB Saunders, 1990: 40515.
  • 22
    Gudjonsson B. Carcinoma of the pancreas: critical analysis of costs, results of resections, and the need for standardized reporting. J Am Coll Surg 1995; 181: 483503.
  • 23
    Snady H, Cooperman A, Bruckner H, Paradiso J. Can endoscopic ultrasonography influence management and outcome of pancreatic cancer? Acta Endoscopica 1995; 25: 51929.
  • 24
    Snady, H. The role of endoscopic ultrasonography in diagnosis, staging, and outcomes of gastrointestinal diseases. Gastroenterologist 1994; 2: 91110.
  • 25
    Siegel JH, Snady H. The significance of endoscopically placed prostheses in the management of biliary obstruction due to carcinoma of the pancreas: results of non-operative decompression in 227 patients. Am J Gastroenterol 1986; 81: 63441.
  • 26
    Snady H, Cooperman A, Siegel J. Endoscopic ultrasonography compared with computed tomography with ERCP in patients with obstructive jaundice or small peripancreatic mass. Gastrointest Endosc 1992; 38: 2734.
  • 27
    Forsmark C. Differential diagnosis of pancreatic tumors. In: Rosch T, editor. Endoscopic ultrasonography. Gastrointest Endosc Clin N Am 1995; 5: 71321.
  • 28
    Snady H, Bruckner H, Siegel J, Cooperman A, Neff R, Kiefer, L. Endoscopic ultrasonographic criteria of vascular invasion by potentially resectable pancreatic tumors. Gastrointest Endosc 1994; 40: 32633.
  • 29
    Snady H, Cooperman A, Siegel, J. Assessment of vascular involvement by pancreatic disease—a comparison of endoscopic ultrasonography to computerized tomography and angiography. Gastrointest Endosc 1990; 36: A197.
  • 30
    Freeny P. Radiology of the pancreas: two decades of progress in imaging and intervention. Am J Radiol 1988; 150: 97581.
  • 31
    Ross C, Sharp K, Kaufman A, Andrews T, Williams L. Efficacy of computerized tomography in the preoperative staging of pancreatic carcinoma. Am Surg 1988; 54: 2216.
  • 32
    Fuhrman G, Charnsangavej C, Abbruzzese J, Cleary K, Martin R, Fenoglio C, et al. Thin-sectoin contrast-enhanced computed tomography accurately predicts the resectability of malignant pancreatic neoplasms. Am J Surg 1994; 167: 10413.
  • 33
    Jafri S, Aisen A, Glazer G, Weiss C. Comparison of CT and angiography in assessing resectability of pancreatic carcinoma. Am J Radiol 1984; 142: 5259.
  • 34
    Cooperman A. Pancreatic and periampullary carcinoma. In: SchwartzS, EllisH, Cowles-HusserW, editors. Maingot's abdominal operations. Norwalk, CT: Appleton & Lange, 1989: 163369.
  • 35
    BeahrsO, HensonD, HutterR, MyersR, editors. Manual for staging of cancer. 3rd ed. American Joint Committee on Cancer. Philadelphia: J.B. Lippincott, 1988.
  • 36
    Snady H. Endoscopic ultrasonography images of the normal retroperitoneum In: Lightdale C, editor. Endoscopic ultrasonography. Gastrointest Endosc Clin N Am 1992; 2: 63755.
  • 37
    Snady H. Identification of major retroperitoneal vascular anatomy with endoscopic ultrasonography. Acta Endoscopia 1995; 25: 4918.
  • 38
    Snady H. Artifacts and techniques of endoscopic ultrasonography in investigating gastrointestinal pathologies and therapeutic options. In: PreedyV, WatsonR, editors. Methods in disease: investigating the gastrointestinal tract. London: Greenwich Med. Media, 1998: 14155.
  • 39
    Snady H, Bruckner H, Cooperman A, Dalton J, Kiefer L. Correlation of endoscopic ultrasonography images and surgical findings of pancreatic tumors after split course radiotherapy plus simultaneous radiopotentiator chemotherapy. J Gastroenterol Hepatol 1997; 12(Suppl): A229.
  • 40
    Ishii H, Okada S, Nose H, Yoshimori M, Aoki K, Okusaka T. Prognostic factors in patients with advanced pancreatic cancer treated with systemic chemotherapy. Pancreas 1996; 12: 26771.
  • 41
    Balen F, Little A, Smith A, Theis B, Abrams K, Houghton J, et al. Biopsy of inoperable pancreatic tumors does not adversely influence patient survival time. Radiology 1994; 193: 7535.
  • 42
    Wade T, Radford D, Virgo K, Johnson F. Complications and outcomes in the treatment of pancreatic adenocarcinoma in the United States veteran. J Am Coll Surg 1994; 179: 3848.
  • 43
    Herter FP, Cooperman AM, Ahlborn TN, Antinori C. Surgical experience with pancreatic and periampullary cancer. Ann Surg 1982; 195: 27481.
  • 44
    Watanapa P, Williamson RCN. Surgical palliation for pancreatic cancer: developments during the past two decades. Br J Surg 1992; 79: 820
  • 45
    Mohiuddin M, Regine W, Stevens J, Rosato F, Barbot D, Biermann W, et al. Combined intraoperative radiation and perioperative chemotherapy for unresectable cancers of the pancreas. J Clin Oncol 1995; 13: 27648.
  • 46
    Burris H III, Moore M, Andersen J, Green MR, Rothenberg ML, Cripps MC, et al. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreatic cancer: a randomized trial. J Clin Oncol 1997; 15: 240313.
  • 47
    Sarr M, Cameron M. Surgical management of unresectable carcinoma of the pancreas. Surgery 1982; 91: 12333.
  • 48
    Shapiro T. Adenocarcinoma of the pancreas: statistical analysis of biliary bypass versus Whipple resection in good risk patients. Ann Surg 1975; 182: 71521
  • 49
    Crile G Jr. The advantages of bypass operations over radical pancreaticoduodenectomy in the treatment of pancreatic carcinoma. Surg Gynecol Obstet 1970; 130: 104953.
  • 50
    Snady H. The role of endoscopic ultrasonography in diagnosis, staging, and outcomes of gastrointestinal diseases. Gastroenterologist 1994; 2: 91110.
  • 51
    Eckstam EE. Survival 13 years after pancreatectomy for ductal adenocarcinoma of the head of the pancreas. Wis Med J 1992; 93: 2669.
  • 52
    Nix G, Schmitz P, Wilson J, Van Blankenstein M, Groeneveld C, Hofwiji R. Carcinoma of the head of the pancreas: therapeutic implications of endoscopic retrograde cholangiopancreatography findings. Gastroenterology 1984; 87: 3743.
  • 53
    Snady H, Bruckner H, Siegel J, Cooperman A, Chesser M, Kiefer L. Influence of combined chemotherapy, radiotherapy and surgery on survival of patients with unresectable pancreatic carcinoma using computed tomography and endoscopic ultrasound to select treatment. Gastroenterology 1994; 106: A28.